BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29729450)

  • 1. New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis.
    Casian A; Sangle SR; D'Cruz DP
    Autoimmun Rev; 2018 Jul; 17(7):660-664. PubMed ID: 29729450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hydroxychloroquine for autoimmune diseases].
    Danza Á; Graña D; Goñi M; Vargas A; Ruiz-Irastorza G
    Rev Med Chil; 2016 Feb; 144(2):232-40. PubMed ID: 27092678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
    Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
    Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pregnancy and vasculitides].
    Pagnoux C
    Presse Med; 2008 Nov; 37(11):1657-65. PubMed ID: 18819771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Neutrophils in Systemic Vasculitides.
    Michailidou D; Mustelin T; Lood C
    Front Immunol; 2020; 11():619705. PubMed ID: 33391289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell-targeted therapy in systemic vasculitis.
    Lally L; Spiera R
    Curr Opin Rheumatol; 2016 Jan; 28(1):15-20. PubMed ID: 26599379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy in ANCA-negative vasculitis.
    Loricera J; Blanco R; Hernández JL; Pina T; González-Vela MC; González-Gay MA
    Int Immunopharmacol; 2015 Aug; 27(2):213-9. PubMed ID: 25828585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis.
    Aristodemou P; Stanford M
    Nat Clin Pract Rheumatol; 2006 Aug; 2(8):443-51. PubMed ID: 16932736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ankle-brachial pressure index: a simple tool for assessing cardiovascular risk in patients with systemic vasculitis.
    Sangle SR; Davies RJ; Mora M; Baron MA; Hughes GR; D'Cruz DP
    Rheumatology (Oxford); 2008 Jul; 47(7):1058-60. PubMed ID: 18499719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancy is increased in ANCA-associated vasculitis.
    Pankhurst T; Savage CO; Gordon C; Harper L
    Rheumatology (Oxford); 2004 Dec; 43(12):1532-5. PubMed ID: 15316126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic presentations of systemic vasculitides.
    Minagar A; Fowler M; Harris MK; Jaffe SL
    Neurol Clin; 2010 Feb; 28(1):171-84. PubMed ID: 19932380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA).
    Weiner M; Segelmark M
    Autoimmun Rev; 2016 Oct; 15(10):978-82. PubMed ID: 27481040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANA (+) ANCA (+) systemic vasculitis associated with the use of minocycline: case-based review.
    Lenert P; Icardi M; Dahmoush L
    Clin Rheumatol; 2013 Jul; 32(7):1099-106. PubMed ID: 23604593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Classification of systemic vasculitides].
    Guillevin L; Pagnoux C
    Rev Prat; 2008 Mar; 58(5):480-6. PubMed ID: 18524103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progranulin antibodies in autoimmune diseases.
    Thurner L; Preuss KD; Fadle N; Regitz E; Klemm P; Zaks M; Kemele M; Hasenfus A; Csernok E; Gross WL; Pasquali JL; Martin T; Bohle RM; Pfreundschuh M
    J Autoimmun; 2013 May; 42():29-38. PubMed ID: 23149338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement system in systemic autoimmune disease.
    Chen M; Daha MR; Kallenberg CG
    J Autoimmun; 2010 May; 34(3):J276-86. PubMed ID: 20005073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of systemic vasculitis: what did we learn in 2009?
    Hellmich B
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):98-103. PubMed ID: 20412713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological therapy of vasculitis: an update.
    Uthman I
    Curr Opin Pharmacol; 2004 Apr; 4(2):177-82. PubMed ID: 15063363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.